Mink Therapeutics Inc
NASDAQ:INKT

Watchlist Manager
Mink Therapeutics Inc Logo
Mink Therapeutics Inc
NASDAQ:INKT
Watchlist
Price: 12.04 USD 3.26%
Market Cap: 56.5m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of INKT.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INKT Intrinsic Value
Not Available
Base Case Scenario
Compare INKT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INKT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mink Therapeutics Inc

Current Assets 14.5m
Cash & Short-Term Investments 14.3m
Other Current Assets 253.1k
Non-Current Assets 429.4k
PP&E 429.3k
Other Non-Current Assets 100
Current Liabilities 13.4m
Accounts Payable 3.7m
Accrued Liabilities 1.3m
Short-Term Debt 5.7m
Other Current Liabilities 2.8m
Non-Current Liabilities 15m
Other Non-Current Liabilities 15m
Efficiency

Free Cash Flow Analysis
Mink Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mink Therapeutics Inc

Revenue
0 USD
Operating Expenses
-12.4m USD
Operating Income
-12.4m USD
Other Expenses
84.1k USD
Net Income
-12.4m USD
Fundamental Scores

INKT Profitability Score
Profitability Due Diligence

Mink Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Exceptional ROE
ROE is Increasing
hidden
Profitability
Score

Mink Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

INKT Solvency Score
Solvency Due Diligence

Mink Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Mink Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INKT Price Targets Summary
Mink Therapeutics Inc

Wall Street analysts forecast INKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.

Lowest
Price Target
35.35 USD
194% Upside
Average
Price Target
39.78 USD
230% Upside
Highest
Price Target
45.15 USD
275% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mink Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INKT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

INKT Insider Trading
Buy and sell transactions by insiders